News and Trends 18 Apr 2016
UK Drug Discovery sells Cancer Target to German Pharma
Boehringer Ingelheim has bought exclusive rights to an oncology target discovered by Oxford BioTherapeutics and its proteomic database. Oxford BioTherapeutics is a Biotech in Milton Park (near Oxford, UK), developing…